vs
Side-by-side financial comparison of SIFCO INDUSTRIES INC (SIF) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $20.6M, roughly 1.2× Entrada Therapeutics, Inc.). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -84.4%, a 91.9% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -65.2%). SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $-39.7M). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs 6.4%).
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
SIF vs TRDA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | ||
|---|---|---|
| Revenue | $24.0M | $20.6M |
| Net Profit | $1.8M | $-17.3M |
| Gross Margin | 21.6% | — |
| Operating Margin | 10.7% | -106.0% |
| Net Margin | 7.5% | -84.4% |
| Revenue YoY | 14.8% | -65.2% |
| Net Profit YoY | 177.3% | -173.8% |
| EPS (diluted) | $0.29 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.0M | — | ||
| Q3 25 | $22.8M | — | ||
| Q2 25 | $22.1M | — | ||
| Q1 25 | $19.0M | $20.6M | ||
| Q4 24 | $20.9M | $37.4M | ||
| Q3 24 | $21.7M | $19.6M | ||
| Q2 24 | $22.0M | $94.7M | ||
| Q1 24 | $20.5M | $59.1M |
| Q4 25 | $1.8M | — | ||
| Q3 25 | $-429.0K | — | ||
| Q2 25 | $3.4M | — | ||
| Q1 25 | $-1.4M | $-17.3M | ||
| Q4 24 | $-2.3M | $1.1M | ||
| Q3 24 | $-443.0K | $-14.0M | ||
| Q2 24 | $72.0K | $55.0M | ||
| Q1 24 | $-1.6M | $23.5M |
| Q4 25 | 21.6% | — | ||
| Q3 25 | 9.6% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 4.4% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | 12.3% | — | ||
| Q1 24 | 7.3% | — |
| Q4 25 | 10.7% | — | ||
| Q3 25 | -1.7% | — | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | -4.1% | -106.0% | ||
| Q4 24 | -9.2% | -15.7% | ||
| Q3 24 | -1.5% | -110.7% | ||
| Q2 24 | 0.7% | 56.4% | ||
| Q1 24 | -6.5% | 35.7% |
| Q4 25 | 7.5% | — | ||
| Q3 25 | -1.9% | — | ||
| Q2 25 | 15.4% | — | ||
| Q1 25 | -7.3% | -84.4% | ||
| Q4 24 | -11.1% | 3.0% | ||
| Q3 24 | -2.0% | -71.7% | ||
| Q2 24 | 0.3% | 58.1% | ||
| Q1 24 | -7.8% | 39.7% |
| Q4 25 | $0.29 | — | ||
| Q3 25 | $-0.07 | — | ||
| Q2 25 | $0.56 | — | ||
| Q1 25 | $-0.23 | $-0.42 | ||
| Q4 24 | $-0.38 | $-0.20 | ||
| Q3 24 | $-0.07 | $-0.35 | ||
| Q2 24 | $0.01 | $1.55 | ||
| Q1 24 | $-0.27 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1M | $67.8M |
| Total DebtLower is stronger | $39.0K | — |
| Stockholders' EquityBook value | $38.7M | $417.3M |
| Total Assets | $74.9M | $486.5M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1M | — | ||
| Q3 25 | $491.0K | — | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $1.9M | $67.8M | ||
| Q4 24 | $3.1M | $101.2M | ||
| Q3 24 | $1.7M | $78.0M | ||
| Q2 24 | $3.4M | $185.3M | ||
| Q1 24 | $2.5M | $68.4M |
| Q4 25 | $39.0K | — | ||
| Q3 25 | $51.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $4.1M | — |
| Q4 25 | $38.7M | — | ||
| Q3 25 | $36.9M | — | ||
| Q2 25 | $35.8M | — | ||
| Q1 25 | $32.4M | $417.3M | ||
| Q4 24 | $33.7M | $428.7M | ||
| Q3 24 | $30.4M | $422.4M | ||
| Q2 24 | $29.8M | $429.9M | ||
| Q1 24 | $29.7M | $269.4M |
| Q4 25 | $74.9M | — | ||
| Q3 25 | $73.4M | — | ||
| Q2 25 | $77.3M | — | ||
| Q1 25 | $78.8M | $486.5M | ||
| Q4 24 | $81.0M | $526.3M | ||
| Q3 24 | $104.6M | $554.6M | ||
| Q2 24 | $106.3M | $582.0M | ||
| Q1 24 | $104.2M | $510.8M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $8.1M | $-38.5M |
| Free Cash FlowOCF − Capex | $8.0M | $-39.7M |
| FCF MarginFCF / Revenue | 33.3% | -192.9% |
| Capex IntensityCapex / Revenue | 0.4% | 5.6% |
| Cash ConversionOCF / Net Profit | 4.51× | — |
| TTM Free Cash FlowTrailing 4 quarters | $11.5M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.1M | — | ||
| Q3 25 | $726.0K | — | ||
| Q2 25 | $371.0K | — | ||
| Q1 25 | $2.8M | $-38.5M | ||
| Q4 24 | $-3.8M | $-31.6M | ||
| Q3 24 | $857.0K | $-24.3M | ||
| Q2 24 | $382.0K | $39.8M | ||
| Q1 24 | $-3.2M | $-25.5M |
| Q4 25 | $8.0M | — | ||
| Q3 25 | $566.0K | — | ||
| Q2 25 | $310.0K | — | ||
| Q1 25 | $2.7M | $-39.7M | ||
| Q4 24 | $-3.9M | $-32.2M | ||
| Q3 24 | $580.0K | $-24.9M | ||
| Q2 24 | $-175.0K | $38.8M | ||
| Q1 24 | $-3.9M | $-26.4M |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 14.1% | -192.9% | ||
| Q4 24 | -18.8% | -86.2% | ||
| Q3 24 | 2.7% | -127.3% | ||
| Q2 24 | -0.8% | 41.0% | ||
| Q1 24 | -18.9% | -44.6% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.8% | 5.6% | ||
| Q4 24 | 0.5% | 1.7% | ||
| Q3 24 | 1.3% | 3.3% | ||
| Q2 24 | 2.5% | 1.1% | ||
| Q1 24 | 3.3% | 1.4% |
| Q4 25 | 4.51× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.31× | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
TRDA
Segment breakdown not available.